Cannabis use disorder clinical trials in Colorado

Mental health

Also: Texas

6 trials are recruiting with sites in Colorado, according to ClinicalTrials.gov.

Checked against the registry on 5 October 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.

Recruiting · Phase 2 · Listed on Beacon

Longitudinal Outpatient Treatment for Cannabis Use Disorder

Ages 21 Years to no maximum · 1 site · in Colorado: Boulder · University of Colorado, Boulder

Details and how to check if you qualify · NCT06107062 on ClinicalTrials.gov

Recruiting · Not applicable

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Ages 18 Years to no maximum · 467 sites · in Colorado: Aurora, Boulder, Centennial, Colorado Springs, Colorado Springs, Denver · Wake Forest University Health Sciences

NCT06418204 on ClinicalTrials.gov

Recruiting · Phase 2

A Study of Cannabidiol in Young Adult Cannabis Users

Ages 18 Years to 25 Years · 1 site · in Colorado: Aurora · University of Colorado, Denver

NCT06569394 on ClinicalTrials.gov

Recruiting · Phase 2

Cannabidiol and Cannabis Concentrate Users

Ages 25 Years to 60 Years · 1 site · in Colorado: Aurora · University of Colorado, Denver

NCT06575751 on ClinicalTrials.gov

Recruiting · Phase 2

Effects of THC on Alcohol Consumption and Neural Correlates of Reward

Ages 21 Years to 40 Years · 1 site · in Colorado: Aurora · University of Colorado, Denver

NCT06446479 on ClinicalTrials.gov

Recruiting · Phase 2 / Phase 3

Alcohol Use Disorder and Cannabidiol

Ages 21 Years to no maximum · 1 site · in Colorado: Aurora · University of Colorado, Denver

NCT05613608 on ClinicalTrials.gov

More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials